Migraine trials in Iran
1 of 1 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleEvaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks
- Where
- Tehran
- Age
- 18 years to 55 years
- People
- 30
- Run by
- Alasht Pharmed
See details and how to joinNCT07093138